MIRUM PHARMACEUTICALS INC (MIRM) Stock Balance Sheet
NASDAQ:MIRM - Nasdaq - US6047491013 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 222.97M | 286.33M | 28.00M | 31.30M | 142.10M | |||
| Marketable Securities | 61.48M | 0.00 | 123.70M | 125.20M | 89.70M | |||
| Receivables | 68.53M | 67.97M | 24.00M | 3.30M | N/A | |||
| Inventories | 21.59M | 22.31M | 5.60M | 1.50M | N/A | |||
| Other Current Assets | 12.06M | 10.94M | 8.90M | 5.30M | 4.50M | |||
| Total Current Assets | 386.63M | 387.54M | 190.20M | 166.60M | 236.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.35M | 1.99M | 2.30M | 2.60M | 3.20M | |||
| Investments And Advances | 9.32M | N/A | 0.00 | 5.00M | 0.00 | |||
| Intangibles | 255.79M | 252.93M | 59.00M | 18.70M | N/A | |||
| Other Non-Current Assets | 5.80M | 4.17M | 101.40M | 101.80M | 1.30M | |||
| Total Non-Current Assets | 281.27M | 259.08M | 162.70M | 128.10M | 4.50M | |||
| TOTAL ASSETS | 667.89M | 646.62M | 352.90M | 294.70M | 240.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 106.21M | 79.65M | 54.90M | 31.40M | 14.00M | |||
| Accounts Payable | 9.54M | 7.42M | 8.70M | 9.20M | 3.20M | |||
| Other Current Liabilities | N/A | 0.00 | 1.10M | 2.00M | 1.30M | |||
| Total Current Liabilities | 115.75M | 87.06M | 64.70M | 42.60M | 18.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 307.67M | 306.42M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 12.45M | 4.47M | 146.10M | 131.80M | 50.30M | |||
| Total Non-Current Liabilities | 320.12M | 310.89M | 146.20M | 131.80M | 50.30M | |||
| TOTAL LIABILITIES | 435.87M | 397.95M | 210.90M | 174.40M | 68.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -620.39M | -556.24M | -392.80M | -257.20M | -173.20M | |||
| Additional Paid In Capital | 851.49M | 803.26M | 535.10M | 377.40M | 345.20M | |||
| Common Shares | 5.00K | 5.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 920.00K | 1.64M | -200.00K | 0.00 | 100.00K | |||
| Shares Outstanding | 47.97M | 46.72M | 37.00M | 30.60M | 29.80M | |||
| Tangible Book Value per Share | -0.50 | -0.09 | 2.24 | 3.32 | 5.78 | |||
| Total Shareholders' Equity | 232.02M | 248.67M | 142.00M | 120.20M | 172.10M | |||
| TOTAL LIABILITIES AND EQUITY | 667.89M | 646.62M | 352.90M | 294.70M | 240.90M | |||
| Statistics | ||||||||
| Debt/Equity | 1.33 | 1.23 | N/A | N/A | N/A | |||
| Current Ratio | 3.34 | 4.45 | 2.94 | 3.91 | 12.78 | |||
| Return On Assets (ROA) | -14.94% | -25.27% | -38.44% | -28.50% | -42.87% | |||
| Return On Equity (ROE) | -43.02% | -65.72% | -95.54% | -69.88% | -60.01% | |||
All data in USD , ROIC based on taxRate of 0.21